Features | No leakage = 49 | Leakage = 64 | P |
---|---|---|---|
Previous chemo/radiotherapy | Â | Â | 0.414 |
 No | 23 (46.9%) | 35 (54.7%) |  |
 Yes | 26 (53.1%) | 29 (45.3%) |  |
Tomita classification | Â | Â | 0.026 |
 Slow | 10 (20.4%) | 19 (29.7%) |  |
 Moderate | 2 (4.1%) | 11 (17.2%) |  |
 Rapid | 37 (75.5%) | 34 (53.1) |  |
Post-OP chemo/radiotherapy | Â | Â | 0.002 |
 No | 5 (10.2%) | 23 (35.9%) |  |
 Yes | 44 (89.8%) | 41 (64.1%) |  |
Other metastasis | Â | Â | 0.795 |
 No | 31 (63.3%) | 42 (65.6%) |  |
 Yes | 18 (36.7%) | 22 (34.4%) |  |
Vertebra level | Â | Â | 0.030 |
 Thoracic | 26 (53.1%) | 21 (32.8%) |  |
 Lumbar | 23 (46.9%) | 43 (67.2%) |  |
Collapse | Â | Â | 0.866 |
 No | 30 (62.5%) | 39 (60.9%) |  |
 Yes | 18 (37.5%) | 25 (39.1%) |  |
Posterior wall destruction | Â | Â | < 0.001 |
 No | 2 (4.1%) | 22 (34.4%) |  |
 Yes | 47 (95.9%) | 42 (65.6%) |  |
Injected laterality | Â | Â | 0.002 |
 Single | 25 (51.0%) | 15 (23.4%) |  |
 Bilateral | 24 (49.0%) | 49 (76.6%) |  |
Injected volume | 5.75 (4.00–6.00) | 4.00 (3.00–6.00) | 0.007 |